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Abstract
The handling and treatment of biological samples is critical when characterizing the composition of the intestinal
microbiota between different ecological niches or diseases. Specifically, exposure of fecal samples to room temperature or
long term storage in deep freezing conditions may alter the composition of the microbiota. Thus, we stored fecal samples at
room temperature and monitored the stability of the microbiota over twenty four hours. We also investigated the stability
of the microbiota in fecal samples during a six month storage period at 280uC. As the stability of the fecal microbiota may
be affected by intestinal disease, we analyzed two healthy controls and two patients with irritable bowel syndrome (IBS). We
used high-throughput pyrosequencing of the 16S rRNA gene to characterize the microbiota in fecal samples stored at room
temperature or 280uC at six and seven time points, respectively. The composition of microbial communities in IBS patients
and healthy controls were determined and compared using the Quantitative Insights Into Microbial Ecology (QIIME)
pipeline. The composition of the microbiota in fecal samples stored for different lengths of time at room temperature or
280uC clustered strongly based on the host each sample originated from. Our data demonstrates that fecal samples
exposed to room or deep freezing temperatures for up to twenty four hours and six months, respectively, exhibit a
microbial composition and diversity that shares more identity with its host of origin than any other sample.
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Introduction
The intestinal microbiota is a complex community of bacteria,
archaea, and eukarya. The bacterial fraction is believed to contain
more than 500 different species and can reach numbers of 1012–
1014 cells/ml of luminal contents [1,2], with the highest densities
residing in the colon. Given this complex microbial community’s
association with disease [3,4], accurate characterization of the
composition and diversity of the intestinal microbiota within
biological samples is of the utmost importance.
Between 40–60% of the bacteria residing within the gut are
reported to be un-culturable [5]. Thus, current research relies
upon DNA-based culture-independent methods for character-
ization of the intestinal microbiota [6,7]. The handling and
treatment of biological samples used to characterize the
intestinal microbiota is critical when comparing the composition
of this complex microbial community between different ecolog-
ical niches or diseases. This is particularly important in studies
investigating the association of the intestinal microbiota with
irritable bowel syndrome (IBS), where fecal samples have been
left at room temperature for up to six hours before isolation of
fecal DNA [8]. A recent report highlighted the significant effect
of ‘length of time’ at ‘room temperature’ (approximately 25uC)
on the composition of the microbiota in a cystic fibrosis sputum
sample, whereas freezing temperatures (220 and 280uC) did
not significantly alter the composition of the microbiota [9].
Additionally, the effect of a range of temperatures (20, 4, 220,
and 280uC) at two time points (3 and 14 days) on the fecal
microbiota has been assessed [10]. This study reported a lack of
effect of time and temperature on the composition of the
microbiota in fecal samples. However, this study compared the
fecal microbiota at three and fourteen days, but did not include
a baseline sample that is reflective of the fecal microbiota at the
time of defecation. Thus, the aim of our study was to
characterize the composition of the microbiota in fecal samples
left at room temperature at baseline (30 minutes following
defecation) and monitor the stability of the microbiota at six
time points over twenty four hours. Additionally, we sought to
investigate the stability of the microbiota in fecal samples at
seven time points during a six month storage period at 280uC.
As the fecal microbiota in healthy individuals and patients with
intestinal disease may be affected differently by the length of
time at a given temperature, we included IBS patients and
healthy controls in our study.
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Materials and Methods
Ethics Statement
The study was approved by the UNC Internal Review Board
(IRB) and all subjects provided written consent prior to
participation in the study.
Study Population
We studied 2 patients that met the Rome III criteria for IBS and
2 healthy controls. Subjects were recruited from the Chapel Hill
general population and from the University of North Carolina
(UNC) healthcare outpatient clinics by advertising.
Inclusion criteria for all subjects were as previously described
[11]. Briefly, subjects 18 years or older, and of any gender, race, or
ethnicity were recruited for this study. Healthy controls had no
recurring GI symptoms. IBS subjects with a history of GI tract
surgery (other than appendectomy or cholecystectomy), a history
of inflammatory bowel diseases (IBD), celiac disease, lactose
malabsorption, or any other diagnosis that could explain chronic
or recurring bowel symptoms were excluded from the study. In
addition, participants were excluded if they had a history of
treatment with antibiotics, anti-inflammatory agents including
aspirin, non-steroid anti-inflammatory drugs (NSAIDs or steroids),
or if they had intentionally consumed probiotics two months prior
to the study. An eight-week wash-out period was required for
subjects who reported intentional consumption of probiotics prior
to enrollment. All subjects were evaluated by a physician to
exclude an alternative diagnosis to IBS.
Sample Collection and Preparation
The strategy for our study is outlined in Figure 1. A fresh stool
sample was collected from all subjects (n = 4) on site and
immediately transported to the laboratory where it was mechan-
ically homogenized with a sterile spatula. Each sample was split
into thirteen aliquots. Each aliquot contained 200 mg of stool in a
sterile 2 ml cryovial. Fecal aliquots were then either stored at (I)
room temperature (approximately 25uC) or (II) 280uC for
different lengths of time. Room temperature: at thirty minutes
following defecation a baseline sample aliquot was transferred to
280uC. Five sample aliquots were then sequentially transferred to
280uC following 1, 4, 6, 8 and 24 hours exposure to room
temperature. Total bacterial DNA was then isolated from all seven
room temperature sample aliquots for each subject. 280uC: at
baseline seven sample aliquots for each subject was transferred to
280uC. Following 1 week at 280uC one sample aliquot for each
subject was removed from storage and total bacterial DNA was
isolated. At 1, 2, 3, 4, 5 and 6 months at 280uC a sample aliquot
for each subject was removed from storage and total bacterial
DNA was isolated. Total bacterial DNA from each sample aliquot
for each subject was used for characterization of the intestinal
microbiota.
Isolation of DNA
Bacterial DNA was isolated from a total of 52 fecal sample
aliquots (4 subjects613 time points) using a phenol/chloroform
extraction method combined with physical disruption of bacterial
cells and a DNA clean-up kit (Qiagen DNeasyH Blood and Tissue
extraction kit [Qiagen, Valencia, CA]) as previously described[11–
13]. Briefly, 100 mg of frozen feces was suspended in 750 ml of
sterile bacterial lysis buffer (200 mM NaCl, 100 mM Tris
[pH 8.0], 20 mM EDTA, 20 mg mL21 lysozyme) and incubated
at 37uC for 30 min. Next, 40 ml of proteinase K (20 mg mL21)
and 85 ml of 10% SDS was added to the mixture and incubated at
65uC for 30 min. 300 mg of 0.1 mm zirconium beads (BioSpec
Products, Bartlesville, OK) was then added and the mixture was
homogenized in a bead beater (TeSeE process 48H, Bertin
Technologies, Le Bretonneux, France) for 90 seconds at
5300 rpm. The homogenized mixture was cooled on ice and then
centrifuged at 14,000 rpm for 5 min (Eppendorf centrifuge
5417R, rotor F45-30-11). The supernatant was transferred to a
new 1.5 ml microfuge tube and fecal DNA was further extracted
by phenol/chloroform/iso-amyl alcohol (25:24:1) and then
chloroform/iso-amyl alcohol (24:1). Following extraction the
supernatant was precipitated by absolute ethanol at 220uC for 1
hour. The precipitated DNA was suspended in DNase free H2O
and then cleaned using the DNeasyH Blood and Tissue extraction
kit (Qiagen, Valencia, CA) from step 3 as per the manufacturer’s
instructions. Prior to microbial characterization, isolated fecal
DNA was stored at 280uC until DNA was obtained from all
samples.
454 Pyrosequencing of 16S rRNA Genes
Bacterial community composition in isolated DNA samples was
characterized as previously described [14]. Briefly, the V1-3
(forward, 8f:59-AGAGTTTGATCMTGGCTCAG-39; reverse
518r: 59-ATTACCGCGGCTGCTGG-39) variable region of the
16S rRNA gene was amplified by polymerase chain reaction
(PCR). Forward primers were tagged with 10 bp unique barcode
labels at the 59 end along with the adaptor sequence (59-
CCATCTCATCCCTGCGTGTCTCCGACTCAG-39) to allow
multiple samples to be included in a single 454 GS FLX Titanium
sequencing plate as previously described [15]. 16S rRNA PCR
products were quantified, pooled, and purified for the sequencing
reaction. 454 GS FLX Titanium sequencing was performed on a
454 Life Sciences Genome Sequencer FLX machine (Roche,
Florence, SC) at the microbiome core at UNC-Chapel Hill
(http://www.med.unc.edu/microbiome).
Analysis of 16S rRNA Sequences using the QIIME Pipeline
16S rRNA sequence data generated by the 454 GS FLX
Titanium sequencer was processed by the quantitative insights into
microbial ecology (QIIME) pipeline [16]. Briefly, sequences that
were less than 200 bp or greater than 1,000 bp in length,
contained incorrect primer sequences, or contained more than 1
ambiguous base were discarded. The remaining sequences were
assigned sample aliquots based on their unique nucleotide
barcodes, including error-correction [17]. Chimeric sequences
Figure 1. Schematic of experimental design.
doi:10.1371/journal.pone.0046953.g001
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were removed using ChimeraSlayer [18]. Sequences were
clustered into Operational Taxonomic Units (OTUs) based on
their sequence similarity at 97% sequence similarity (similar to
species level) using UCLUST [19]. A representative sequence for
each OTU was chosen for downstream analysis based on the most
abundant sequence from each OTU. PyNAST was used to align
sequences with a minimum length of 150 bp and a minimum
percent identity of 75.0 [20]. OTUs were assigned to a taxonomy
using the Ribosomal Database Project (RDP) Naive Bayes
classifier v 2.2 with the confidence level set at 0.8 [21]. b-diversity
(diversity between groups of samples) was used to generate
principal coordinate plots for each sample using un-weighted
and weighted UniFrac distances[22–24]. PCoA plots were used to
visualize the similarities or dissimilarities of variables that best
represent the pair-wise distances between sample groups.
Statistical Analysis
Before statistical comparisons were made bacterial taxa
percentages and average UniFrac value data sets were assessed
for normality using the D’Agostino and Pearson omnibus
normality test. When a data set was identified as not having a
normal distribution it was transformed by log10 [25], and retested
for normality. Data sets normally distributed were compared using
a Student’s t-test. All statistical comparisons were carried out using
GraphPad software (v4.0a; Prism, San Diego, CA). We used taxon
and phylogenetic-based analyses to compare 16S rRNA gene
sequences within IBS patients and healthy controls over time at
room temperature or 280uC. Taxon-based: The means and
standard deviations of abundances of bacterial groups (Phylum,
Class, Order, Family, and Genus) and OTUs were calculated and
compared between all samples stored at room temperature and
280uC, and between samples stored at room temperature and
280uC for each individual. A p value of less than 0.05 was
considered significant after testing for multiple comparisons using
Bonferroni correction. Zero values for taxa and OTUs were
considered as absences and not included when calculating
averages. Phylogenetic-based: Phylogenetic trees for IBS patients
and healthy controls were generated using the QIIME pipeline
[16]. Each tree was subjected to weighted and unweighted
UniFrac analysis[22–24] through the QIIME pipeline. UniFrac
distances represent the fraction of branch length that is shared by
any two samples’ communities in a phylogenetic tree built from
16S rRNA sequence data from all samples. Statistical differences
between groups of samples (i.e. room temperature versus 280uC
samples, and room temperature and 280uC samples from each
individual) were tested using analysis of similarity (ANOSIM –
available through QIIME) by permutation of group membership
with 999 replicates. The test statistic R, which measures the
strength of the results, ranges from 21 to 1: R = 1 signifies
differences between groups, while R = 0 signifies that the groups
are identical.
Results
I. Characterization of Microbial Communities in IBS and
HC Fecal Samples
A total of 201,101 16S rRNA sequences with acceptable quality
were obtained from 52 fecal samples (4 subjects613 aliquots) with
an average of 3,867 reads (range: 1,552–6,531) per sample (HC:
4,309 reads per sample, on average, with a range of 1,936–6,531;
IBS: 3,426 reads per sample, on average, with a range of 1,552–
5,797). 18.14% of the total number of sequences were found to be
chimeric and removed from further analyses. In order to
determine the number and abundances of different bacterial
groups in each sample we used 3% dissimilarity between 16S
rRNA gene sequences as an indicator of a ‘species level’ OTU.
Using this procedure, we found a total of 8,334 OTUs in all
samples obtained from the 4 subjects. The 16S rRNA sequence
data for this study is publically available at the QIIME website
(www.microbio.me/qiime) under the title ‘storage study’.
II. Stability of Fecal Microbial Communities During
Storage
To compare the global composition of the microbiota in HC
and IBS fecal samples stored at room temperature and 280uC for
different lengths of time UniFrac distances[22–24] were calculated
and compared between sample aliquots. Principal Coordinate
Analysis (PCoA) of weighted and unweighted UniFrac distances
for all sample aliquots stored at room temperature or 280uC
(n = 52) revealed four distinct clusters (Figure 2 A&E). Each cluster
contained samples obtained from one subject for all time points at
both room temperature and 280uC. Additionally, each cluster
contained samples obtained from one subject for all time points.
PCoA plots of unweighted UniFrac distances revealed no
significant clustering of samples based on storage temperature.
PCoA plots of weighted UniFrac distances revealed no significant
clustering of samples based on storage temperature for both HC
samples and one IBS sample, however samples from one IBS
individual (IBS1) exhibited clustering based on storage tempera-
ture (Figure 2 B&F). ANOSIM confirmed that the samples from
the two HC and one IBS individual did not cluster based on
storage temperature (HC1: unweighted Unifrac - R = 0.16
p = 0.07, weighted UniFrac - R = 0.01 p = 0.39; HC2: unweighted
Unifrac - R = 0.07 p = 0.72, weighted UniFrac - R = 0.07 p = 0.22;
IBS2: unweighted Unifrac - R = 20.05 p = 0.70, weighted UniFrac
- R = 0.14 p = 0.08), and that samples from one IBS individual did
cluster based on storage temperature (IBS1: unweighted Unifrac -
R = 20.01 p = 0.48, weighted UniFrac - R = 0.21 p = 0.04).
Average weighted and unweighted UniFrac distances calculated
based on the ‘host of origin’ were found to be significantly lower
(p,0.05) when compared to UniFrac distances calculated based on
the length of time a sample was stored at room temperature or
280uC (Figure 2 C,D,G&H), indicating that the microbiota in
fecal samples are more similar within the individual of origin when
compared to the length of time at a storage temperature.
Interestingly, the combined average weighted UniFrac distances
for HCs were significantly lower (p,0.05) than the combined
average weighted UniFrac distances for IBS subjects. This
significant decrease was not observed in the unweighted analysis,
indicating that HC samples may be more stable than IBS samples
during storage based on the relative abundances of specific OTUs.
III. Stability of Bacterial Groups During Storage
The percentages of bacterial taxa displayed a non-normal
distribution that was likely due the presence of zero values in the
data set. All data sets exhibited a normal distribution following
log10 transformation. Although we observed a significant separa-
tion of the composition of the microbiota between samples stored
at room temperature and 280uC in one IBS individual (IBS1), we
were unable to identify any specific OTUs that were significantly
different in concentration between the storage temperatures in any
of the four individuals investigated (Table 1). Additionally, the
abundance of different bacterial taxa identified by OTU sequence
alignments were not found to significantly fluctuate in IBS patients
and HC over time during storage at either room temperature or
280uC. Figure 3 displays the variation of dominant phyla in fecal
samples during storage. The Bacteroidetes and Proteobacteria
phyla exhibited higher concentrations in IBS patients (Figure 3). It
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has been previously reported by our research group that the
Proteobacteria phylum and Gammaproteobacteria class are
significantly elevated in IBS patients [14]; however, the Bacter-
oidetes phylum was not found to be associated with IBS.
Discussion
Until the advent of DNA-based methods to characterize
complex bacterial communities in biological samples, it was
widely accepted that human fecal samples must be immediately
frozen upon collection in order to preserve the composition of the
microbiota [26]. This assumption proved practically difficult in
human clinical trials, where collected fecal samples could be
exposed to room temperature for hours before reaching the
laboratory. Additionally, depending on the speed of subject
recruitment, fecal samples may have to be stored in deep freezing
conditions for long periods of time before isolating DNA.
A recent study using high throughput pyrosequencing of the
16S rRNA gene revealed that the phylogenetic structure of the
microbiota did not significantly differ between three- and fourteen-
day old fecal samples stored at a range of temperatures (20, 4, 220
and 280uC) [10]. However, Lauber et al’s [10] study lacked a
baseline sample representing the structure of the fecal microbiota
immediately following defecation. Thus, it is possible that the
microbiota in fecal samples degraded rapidly and maintained this
composition over time. To address these points we designed a
study where a baseline aliquot (30 minutes following defecation)
was collected and compared to aliquots of the same sample stored
at room temperature over a twenty four hour period. We also
investigated the stability of the fecal microbiota from aliquots of
the same samples stored at 280uC over six months. Furthermore,
as fecal samples from ulcerative colitis and IBS patients have
significantly higher protease activity [27], it is possible that the
fecal microbiota from individuals with intestinal disease may be
affected differently by the length of exposure to room or freezing
temperatures. Thus, healthy individuals and IBS patients were
included in this study.
When directly comparing the composition of the intestinal
microbiota from all subjects and samples stored at room
temperature using UniFrac distances[22–24], we found that
samples segregated based on the subject they originated from
rather than the length of time they were exposed to room
temperature. This finding suggests that fecal samples kept at
room temperature for up to twenty four hours retain a
microbiota that is similar in composition to a fresh sample from
that individual. Likewise, during long-term storage at 280uC, we
found the composition of the microbiota from all subjects and
samples segregated based on the subject they originated from
rather than the length of time they were exposed to deep freezing
conditions. This finding suggests that fecal samples kept at
280uC for up to six months also retain a microbiota that is
similar in composition to a fresh sample from that individual.
However, we found that the composition of the microbiota from
samples stored at room temperature significantly segregated from
the microbiota of samples stored at 280uC for one IBS
individual. The samples from the second IBS individual did
not display the same significant separation between storage
temperatures; however clustering of samples on a weighted PCoA
displayed greater variation when compared to HC, implying that
the microbiota from this IBS patient may also be less stable at
room temperature to that of healthy controls. Indeed, the
microbiota from both HC samples exhibited lower average
weighted UniFrac values than the microbiota from both IBS
samples. In support of this observation, our weighted PCoA
analysis shows that HC samples cluster tighter than IBS samples.
This observation suggests that abundant taxa in the HC samples
in our study are less affected by temperature than the IBS
analyzed in our study. Although, the IBS samples we analyzed
Figure 2. b-diversity analysis of samples. Principal coordinates analysis (PCoA) of weighted and unweighted UniFrac distances of IBS patient
(green and orange triangles) and healthy control (blue squares and red circles) fecal sample aliquots exposed to room temperature and 280uC for
different lengths of time (room temperature - 1, 4, 6, 8 and 24 hours; 280uC 21 week and 1, 2, 3, 4, 5 and 6 months). PCoA plots illustrate the subject
each sample aliquot originated from (A&E) and the temperature they were stored at (B&F). Average weighted UniFrac distances for all sample
aliquots based on storage at room temperature (C&G) or 280uC (D&H) indicate that sample aliquot microbiotas show significantly similarity
(*p,0.05).
doi:10.1371/journal.pone.0046953.g002
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were more affected by storage temperature than HC, the
microbiota in these samples bore more similarity to their
individual of origin than to storage temperature, and we did
not identify any specific OTU or higher taxonomic group that
significantly differed between storage temperatures in IBS
individuals. This indicates that although IBS samples stored at
room temperature for up to 24 hours may alter in microbial
composition, these samples still closely represent the intestinal
microbiota of that individual. It is unclear why the microbiota of
IBS fecal samples are less stable during storage at room
temperature, however as intestinal metabolites are altered in
IBS patients [27,28] it is tempting to speculate that elevated
levels of proteases and acids may result in faster degradation of
fecal DNA.
Our study reports a relatively stable microbiota in fecal samples
stored at room temperature or 280uC over time, however we do
not see identical bacterial compositions in all samples from the
same host. It has been reported that the length of time at different
storage temperatures affects the densities of specific bacterial
groups [29] in swine feces. Although we did not see a significant
effect of length of time at a storage temperature on bacterial
taxonomic groups or individual species-level OTUs, our analysis
did not provide the resolution to investigate fluctuations of taxa at
the species or strain level. Additionally, we did not investigate the
stability of the microbiota in fecal samples between 8 and 24 hours
at room temperature, where the microbiota may be less stable. It is
also important to note that although we generated a relative large
number of sequences per sample, our depth of coverage will not
detect very low abundant taxa. It is, therefore, possible that low
abundance taxa may be affected by storage temperature.
Furthermore, fecal DNA used in our study to characterize the
microbiota of fecal samples was stored at 280uC for different
lengths of time, and we have not investigated that stability of fecal
DNA over time during freezing conditions.
In conclusion we report that fecal samples exposed to room or
deep freezing temperatures for up to twenty four hours and six
months, respectively, exhibit a microbial composition and diversity
that shares more identity with its host of origin than any other
sample. This study validates the approach of storing samples at
280uC until a full complement of fecal samples is acquired in
order to investigate the composition of the fecal microbiota in
healthy controls and IBS patients.
Figure 3. Abundances of dominant phyla in samples. Abundances (% of total 16S rRNA sequences) of the predominant bacterial phyla in
healthy control and IBS patient fecal sample aliquots exposed to room temperature and 280uC for different lengths of time.
doi:10.1371/journal.pone.0046953.g003
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Table 1. OTUs most significantly altered between room temperature and 280uC storage for all samples and each individual.








All Samples 5780 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.006 5.951 1.59610204 2.44610205
5434 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.010 9.992 1.11610204 2.55610205
4167 Firmicutes;Clostridia;Clostridiales 0.014 14.530 1.86610204 2.52610205
1710 Bacteroidetes;Bacteroidia;Bacteroidales;Rikenellaceae;Alistipes 0.029 29.303 2.72610204 7.03610205
8336 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.032 32.433 2.48610204 5.12610205
135 Bacteroidetes;Bacteroidia;Bacteroidales;Bacteroidaceae;Bacteroides 0.033 33.398 1.73610205 9.33610205
3326 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.035 35.958 1.79610204 5.49610205
6032 Bacteria 0.038 38.225 1.16610204 2.70610205
7971 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.039 39.843 2.55610205 1.96610204
142 Firmicutes;Clostridia;Clostridiales;Incertae Sedis XIV;Blautia 0.042 42.308 1.89610203 2.85610203
IBS 1 2064 Bacteroidetes;Bacteroidia;Bacteroidales;Prevotellaceae;Prevotella 0.003 0.387 4.67610204 1.94610203
6839 Firmicutes;Clostridia;Clostridiales 0.006 0.799 7.61610203 3.18610203
7540 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.027 3.486 1.57610202 9.06610203
8513 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.031 3.996 1.82610202 1.52610202
7603 Bacteroidetes;Bacteroidia;Bacteroidales;Prevotellaceae;Prevotella 0.042 5.304 8.87610204 2.25610203
6717 Firmicutes;Clostridia;Clostridiales 0.051 6.425 8.86610204 4.02610204
2944 Bacteroidetes;Bacteroidia;Bacteroidales;Bacteroidaceae;Bacteroides 0.051 6.483 1.02610202 6.57610203
3846 Bacteroidetes;Bacteroidia;Bacteroidales;Bacteroidaceae;Bacteroides 0.058 7.373 1.04610203 4.19610204
6927 ProteoGammaproteoEnterobacteriales;Enterobacteriaceae;Escherichia/
Shigella
0.060 7.682 6.64610203 2.16610203
8068 Firmicutes;Clostridia;Clostridiales 0.061 7.693 1.57610203 7.12610
204
IBS 2 5681 Firmicutes;Clostridia;Clostridiales;Eubacteriaceae;Eubacterium 0.002 0.723 4.49610204 1.46610203
5276 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae;Dorea 0.003 0.815 1.47610204 5.22610204
6589 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Oscillibacter 0.006 1.912 2.80610202 1.43610202
1971 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.006 1.929 1.14610202 5.07610203
6815 Bacteria 0.009 2.685 2.82610204 8.56610204
6631 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.011 3.388 1.21610203 3.98610204
343 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.013 3.829 2.87610204 8.79610204
8906 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.014 4.109 2.25610204 7.60610204
9044 Firmicutes;Clostridia;Clostridiales 0.017 5.211 9.61610204 3.06610203
6399 Firmicutes;Clostridia;Clostridiales;Incertae Sedis XIV;Blautia 0.022 6.721 7.31610204 1.29610203
HC 1 452 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.003 0.849 1.57610203 9.82610204
3634 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.005 1.636 5.67610204 1.95610204
3163 Firmicutes;Clostridia;Clostridiales;Incertae Sedis XIV;Blautia 0.013 4.101 5.69610203 3.27610203
809 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae;Roseburia 0.014 4.507 2.36610204 5.49610204
9486 ProteoBetaproteoBurkholderiales;Alcaligenaceae;Parasutterella 0.015 4.755 9.26610204 1.70610203
6663 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.024 7.418 3.50610204 1.53610204
4191 Bacteria 0.026 8.003 1.70610203 8.91610204
6951 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.031 9.599 5.31610204 2.58610204
3893 Firmicutes;Clostridia;Clostridiales 0.033 10.175 8.86610204 1.68610203
7567 Firmicutes;Clostridia;Clostridiales;Incertae Sedis XIV;Blautia 0.039 12.077 4.77610204 1.06610203
HC 2 5281 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae 0.001 0.259 5.01610204 1.63610203
1331 Firmicutes;Clostridia;Clostridiales;Lachnospiraceae 0.004 1.039 1.89610204 1.27610203
379 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.006 1.291 2.03610203 8.78610204
8605 Firmicutes;Clostridia;Clostridiales 0.008 1.880 4.71610204 1.41610203
142 Firmicutes;Clostridia;Clostridiales;Incertae Sedis XIV;Blautia 0.017 3.977 2.92610203 4.81610203
3095 Firmicutes;Clostridia;Clostridiales 0.019 4.397 1.68610203 3.02610203
331 Firmicutes 0.023 5.269 6.00610204 1.46610203
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Table 1. Cont.








2380 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.023 5.348 1.41610203 6.28610204
9034 Firmicutes;Clostridia;Clostridiales;Ruminococcaceae;Faecalibacterium 0.024 5.489 5.86610203 3.71610203
9044 Firmicutes;Clostridia;Clostridiales 0.024 5.659 4.21610203 6.87610203
doi:10.1371/journal.pone.0046953.t001
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